Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 15:46:41 GMT 2023
by
admin
on
Sat Dec 16 15:46:41 GMT 2023
|
| Protein Sub Type | |
| Record UNII |
BZY4UC5GQT
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
PDCD1LG2
Created by
admin on Sat Dec 16 15:46:41 GMT 2023 , Edited by admin on Sat Dec 16 15:46:41 GMT 2023
|
PRIMARY | |||
|
BZY4UC5GQT
Created by
admin on Sat Dec 16 15:46:41 GMT 2023 , Edited by admin on Sat Dec 16 15:46:41 GMT 2023
|
PRIMARY | |||
|
Q9BQ51
Created by
admin on Sat Dec 16 15:46:41 GMT 2023 , Edited by admin on Sat Dec 16 15:46:41 GMT 2023
|
PRIMARY |
| From | To |
|---|---|
| 1_124 | 1_173 |
| 1_23 | 1_83 |
| Glycosylation Type | HUMAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_18 |
| N | 1_45 |
| N | 1_138 |
| N | 1_144 |
| N | 1_170 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> AGONIST |
PD-L2 binds to its receptor PD-1 with dissociation constant Kd of 11.3 nM.[16] Binding to PD-1 can activate pathways inhibiting TCR/BCR-mediated immune cell activation
BINDING
Kd
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|